Table 2.
Comparison of ocular clinical features of patients with CMV-positive and CMV-negative Posner-Schlossman syndrome
| Characteristics | CMV-Negative Patients (N = 22) |
CMV-Positive Patients (N = 25) |
P Valuea |
|---|---|---|---|
| IOP at the clinic visit (mm Hg) | 29.6 (24.5–34.8) | 29.0 (25.0–33.0) | .839 |
| Peak IOP (mm Hg) | 48.5 (44.4–52.6) | 49.2 (41.3–57.1) | .235 |
| Cup-to-disc ratio | 0.5 (0.4–0.5) | 0.6 (0.5–0.6) | .043* |
| Corrected visual acuity | |||
| logMAR | 0.1 (0.02–0.2) | 0.3 (0.01–0.6) | .554 |
| Decimal (minutes) | 0.8 (0.7–0.9) | 0.8 (0.6–0.9) | .554 |
| CEC density of the diseased eye (cell/mm2) | 2490.6 (2320.8–2660.5) | 2196.3 (2020.9–2371.8) | .017* |
| CEC destiny of the healthy eye (cell/mm2) | 2756.6 (2596.3–2916.9) | 2828.5 (2702.2–2954.8) | .448 |
| Relative CEC loss (%) | 9.6 (5.9–13.3) | 22.1 (16.3–27.9) | .001* |
| KPs | |||
| -Mutton-fat | 19 (86.36) | 25 (100) | .095 |
| -Coin-shaped | 5 (22.7) | 6 (24.0) | .894 |
| Tyndall effect | 3 (13.6) | 3 (12.0) | 1.000 |
| Iris depigmentation | 9 (40.9) | 20 (80.0) | .006* |
| Cataract | 6 (27.3) | 13 (52.0) | .085 |
Data are expressed as mean (95% C.I) or number of patients (%)
IOP Intraocular pressure, CEC Corneal endothelial cell, KPs Keratic precipitates
aχ2 test or Fisher’s exact test was used to compare proportions between CMV-negative and CMV-positive PSS; Mann-Whitney U test was used to compare continuous variables between CMV-negative and CMV-positive PSS
*p < .05